Johnson & Johnson said ​on Wednesday the U.S. ‌Food and Drug Administration had granted marketing authorization ​for its robotic surgery ​device, clearing the way ⁠for the healthcare conglomerate ​to enter the soft-tissue ​robotic surgery market.